Page Content
2020
- Waitzberg R, Quentin W, Daniels E, Paldi Y, Busse R, Greenberg D (2020): Effects of Activity-Based Hospital Payments in Israel: A Qualitative Evaluation Focusing on the Perspectives of Hospital Managers and Physicians.
- Quentin W, Busse R, Vogt V, Czihal T, Offermanns M, Grobe T, Focke K (2020): Entwicklungen eines Systems zur Klassifikation des morbiditätsbezogenen Versorgungsbedarfs (PopGroup).
- Brammli-Greenberg S, Waitzberg R (2020): Integrating public and private insurance in the Israeli health system: an attempt to reconcile conflicting values.
- van Ginneken E, Waitzberg R, Barnes A, Quntin W, Smatana M, Rice T (2020): Achieving Person-Centred Health Systems: Evidence, Strategies and Challenges.
2019
- Waitzberg R, Quentin W, Daniels E, Perman V, Brammli-Greenberg S, Busse R, Greenberg D (2019): The 2010 expansion of activity-based hospital payment in Israel: an evaluation of effects at the ward level
- Hsiao A, Vogt V, Quentin W (2019): Effect of corruption on perceived difficulties in healthcare access in sub-Saharan Africa.
- Brammli-Greenberg S, Glazer J, Waitzberg R (2019): Modest risk-sharing significantly reduces health plans’ incentives for service distortion.
2016
- Ekman I, Busse R, van Ginneken E, van Hoof C, van Ittersum L, Klink A, Kremer JA, Miraldo M, Olauson A, de Raedt W, Rosen-Zvi M, Strammiello V, Törnell J, Swedberg K (2016): Health-care improvements in a financially constrained environment.
- van Ginneken E (2016): Governing competitive insurance market reform: case studies from the Netherlands and Switzerland
2015
- Busse R, Blümel M (2015): Payment systems to improve quality, efficiency, and care coordination for chronically ill patients - a framework and country examples. In: Mas N, Wisbaum W (eds.) The triple aim for the future of health care. Madrid: Funcas
- Panteli D, Eckhardt H, Nolting A, Busse R, Kulig M (2015): From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries. Health Research Policy and Systems
- Pimperl A, Schreyögg J, Rothgang H, Busse R, Glaeske G, Hildebrandt H: Ökonomische Erfolgsmessung von integrierten Versorgungsstrukturen – Gütekriterien, Herausforderungen, Best-Practice-Modell. Das Gesundheitswesen (DOI 10.1055/s-0034-1381988)
2014
- Busse R, Blümel M (2014): Sistemas de pago para mejorar la calidad, eficiencia y coordinación de la atención a los pacientes crónicos. Un marco y ejemplos nacionales. Papeles de Economía Española; 142: 50-61
- Van der Wees PJ, Nijhuis-van der Sanden MW, van Ginneken E, Ayanian JZ, Schneider EC, Westert GP (2014): Governing healthcare through performance measurement in Massachusetts and the Netherlands. Health Policy. 2014 May;116(1):18-26.
- Vuong DA, Flessa S, Marshall P, Luong KN, Ha ST, Busse R (2014): Determining the impacts of hospital cost-sharing on the uninsured near-poor households in Vietnam. International Journal for Equity in Health 13: 40
2013
- Busse R , Schreyögg J, Stargardt T (Hrsg.) (2013): Management im Gesundheitswesen. Das Lehrbuch für Studium und Praxis. 3., vollständig überarbeitete und erweiterte Auflage. Berlin-Heidelberg: Springer
- Ismail F, Busse R (2013): Die Herausforderungen für gesetzliche Krankenkassen bei der Steuerung der Versorgung von Hochkostenfällen. In: Burger S (Hrsg.) Alter und Multimorbidität. Berlin: medhochzwei, S. 447-463
- McKee M, Busse R (2013): Medical savings accounts: Singapore’s non-solution to healthcare costs. BMJ 347: f4797
- Stabile M, Thomson S, Allin S, Boyle S, Busse R, Chevreul K, Marchildon G, Mossialos E (2013): Health Care Cost Containment Strategies Used In Four Other High-Income Countries Hold Lessons For The United States. Health Affairs 32(4): 643-652
2008
- Schreyögg J (2008): A micro-costing approach to estimating hospital costs for appendectomy in a Cross-European. Health Economics 17(S1): S59-S69
- Schreyögg J, Tiemann O, Stargardt T, Busse R (2008): Cross-country comparisons of costs: the use of episode-specific transitive purchasing power parities with standardised cost categories. Health Economics 17(S1): S95-S103
- Stargardt T (2008): Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries. Health Economics 17(S1): S9-S20
- Stargardt T, Weinbrenner S, Busse R, Juckel G, Gericke CA (2008): Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care. J Ment Health Policy Econ; 11: 89-97.
- Tiemann O (2008): Variations in hospitalisation costs for acute myocardial infarction - a comparison across Europe. Health Economics 17(S1): S33-S45
2006
- Busse R (2006): Health economics. Objectives, methodology, relevance - Gesundheitsschutz 49(1): 3-10
- Auerbach H, Schreyögg J, Busse R (2006): Cost-effectiveness Analysis of Telemedical Devices for Pre-clinical Traffic Accident Emergency Rescue in Germany. Technology and Health Care 14(3): 189-197
- Grabka M, Schreyögg J, Busse R(2006):The impact of co-payments on patient behavior: evidence from a natural experiment
- Schreyögg J, Hollmeyer H, Staab D, Bluemel M, Busse R (2006): Hospitalization costs of cystic fibrosis – identifying homogenous cost-groups and determining predictors for cost variation. Pharmacoeconomics 24(10): 999-1009
- What makes the difference? Analysing methodologies to determine DRGs in nine European countries
- Schreyögg J, Tiemann O, Busse R (2006): Cost accounting to determine prices: how well do prices reflect costs in the German DRG-system? Health Care Management Science 9(3): 269-279
Zusatzinformationen / Extras
Quick Access:
Schnellnavigation zur Seite über Nummerneingabe